The Valley Desk

Clinical trial reportBreast cancer research and treatmentPublished

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Breast cancer research and treatment
Published
Subject terms
Humans; Breast Neoplasms; Aminopyridines; Paclitaxel; Cyclophosphamide; Pyrroles; Doxorubicin; Antineoplastic Combined Chemotherapy Protocols; Neoplasm Staging; Treatment Outcome; Neoadjuvant Therapy; Adult
PubMed ID
39625569
PubMed Central ID
PMC11785665
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal